Ingredient Layering
Can I Use EGF (Epidermal Growth Factor) and Matrixyl (Palmitoyl Pentapeptide-4) Together?
Great Together
EGF (Epidermal Growth Factor) and Matrixyl (Palmitoyl Pentapeptide-4) work great together!
What You Should Know
- •These ingredients complement each other and can be used in the same routine.
- •Apply in order of thinnest to thickest consistency.
- •Both can be used in the same routine step without conflicts.
Recommended Layering Order
Step 1
EGF (Epidermal Growth Factor)
peptide
Step 2
Matrixyl (Palmitoyl Pentapeptide-4)
peptide
General rule: apply thinnest/most active ingredients first, thicker/occlusive ingredients last.
peptide
The ingredient that won Kári Stefánsson a genetics Nobel and became the reason BIOEFFECT exists — a real signalling peptide with a very specific job, priced like a small mortgage.
peptide
The peptide with the best clinical evidence — stimulates collagen synthesis without the irritation of retinoids.
More Layering Combos
What pairs with EGF (Epidermal Growth Factor)?
What pairs with Matrixyl (Palmitoyl Pentapeptide-4)?
Frequently Asked Questions
Can I use EGF (Epidermal Growth Factor) and Matrixyl (Palmitoyl Pentapeptide-4) together?
EGF (Epidermal Growth Factor) and Matrixyl (Palmitoyl Pentapeptide-4) work great together! They can be layered in the same K-beauty routine.
Should I apply EGF (Epidermal Growth Factor) before or after Matrixyl (Palmitoyl Pentapeptide-4)?
Apply thinnest/most active first. Based on their categories, apply EGF (Epidermal Growth Factor) first, then follow with the other.
Are there products with both EGF (Epidermal Growth Factor) and Matrixyl (Palmitoyl Pentapeptide-4)?
We don't currently track any products that combine EGF (Epidermal Growth Factor) and Matrixyl (Palmitoyl Pentapeptide-4) as key ingredients. Layering two separate products is the typical approach.
Is EGF (Epidermal Growth Factor) stronger than Matrixyl (Palmitoyl Pentapeptide-4)?
EGF (Epidermal Growth Factor) has 3/5 clinical evidence; Matrixyl (Palmitoyl Pentapeptide-4) has 3/5. They have similar clinical backing.